Title: Mofegiline
CAS Registry Number: 119386-96-8
CAS Name: (bE)-4-Fluoro-b-(fluoromethylene)benzenebutanamine
Additional Names: (E)-2-(fluoromethylene)-4-(p-fluorophenyl)butylamine; (E)-2-(4-fluorophenethyl)-3-fluoroallylamine
Molecular Formula: C11H13F2N
Molecular Weight: 197.22
Percent Composition: C 66.99%, H 6.64%, F 19.27%, N 7.10%
Literature References: Irreversible monoamine oxidase-B (MAO-B) inhibitor. Prepn: I. A. McDonald, M. G. Palfreyman, EP 295604 (1988 to Merrell Dow). GC-MS determn in plasma and urine: B. D. Dulery et al., J. Chromatogr. 571, 241 (1991). Pharmacokinetics: eidem et al., Arzneim.-Forsch. 43, 297 (1993). Metabolism: J. Dow et al., Drug Metab. Dispos. 22, 738 (1994). Clinical pharmacology: C. Hinze et al., J. Neural Transm. Suppl. 41, 371-375 (1994). Clinical evaluation in Parkinson's disease: V. V. Myllylä et al., Adv. Neurol. 60, 676 (1993).
Derivative Type: Hydrochloride
CAS Registry Number: 120635-25-8
Manufacturers' Codes: MDL-72974A
Molecular Formula: C11H13F2N.HCl
Molecular Weight: 233.69
Percent Composition: C 56.54%, H 6.04%, F 16.26%, N 5.99%, Cl 15.17%
Properties: Colorless plates, mp 131°.
Melting point: mp 131°
Therap-Cat: Antiparkinsonian.
Keywords: Antiparkinsonian; Monoamine Oxidase Inhibitor.
Status: This monograph has been retired and is no longer subject to revision or update. |